Brief: IX Biopharma Posts QTRLY Loss From Cont. Ops S$2.8 MLN
09/05/2019 12:24
May 9 (Reuters) - IX Biopharma Ltd IXBI.SI :
* QTRLY LOSS FROM CONTINUING OPERATIONS S$2.8 MILLION VERSUS
LOSS
OF S$4.1 MILLION
Source text for Eikon: ID:nSNZ2JyGyn
Further company coverage: IXBI.SI
((Reuters.Briefs@thomsonreuters.com;))
Recent news on IX Biopharma
See all newsBrief: IX Biopharma Says Co Will Undertake An Internal Restructuring Of Its Consumer Business
Brief: IX Biopharma To Issue 1 MLN New Shares To Anson Properties At S$0.4215 Per Share
Brief: IX Biopharma Says US Government Awards US$41 MLN Contract To Fund Development Of Wafermine
Brief: IX Biopharma To Raise At Least S$6 MLN Via Placement At S$0.198 Per Share
Brief: IX Biopharma Enters Term Sheet For Proposed Joint Venture